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This edition of Select highlights recent papers that explore some of the ever-evolving strategies that are
used by microbes to subvert eukaryotic immune systems, and by host cells to fight off bacterial and viral
pathogens.
Shigella Forges a Path to Pathogencity
A number of intracellular pathogens, including Shigella flexneri, the causative agent of
dysentery, co-opt the cytoskeletal elements of their host cells. These bacterial patho-
gens nucleate actin tails at one of their cell poles that enable them to propel them
through the cytoplasm and invade neighboring host cells. The motility patterns of
the bacterial cells vary in speed and in the number of stops and turns made in their
journey. Yoshida et al. (2006) now report that Shigella’s ease of movement is greatly
impeded by host cell microtubules. It turns out that Shigella secretes a protease-like
protein, VirA, that fragments microtubules thus clearing a path for itself and other
bacteria. A Shigella mutant lacking VirA has dramatically reduced motility within
infected cells despite forming normal actin tails. Treating the infected cells with noco-
dazole, a microtubule-depolymerizating agent, rescues the motility defect of the
mutant Shigella and enhances the speed and efficiency of the wild-type bacterium.
‘‘Tunnels’’ of cleared microtubules coincident with the path of wild-type Shigella
can be visualized, and other bacteria tend to follow the lead bacterium along the
same path. Higher-resolution imaging revealed microtubule fragments in the wake
of the pioneering bacterium. The virA mutant Shigella could not forge ‘‘tunnels,’’ indicating that VirA was the agent
of microtubule demise. Indeed, purified VirA could fragment microtubules in vitro, and further biochemical charac-
terization revealed that VirA degrades a-tubulin via cysteine protease activity. A strain of S. flexneri bearing a muta-
tion at VirA’s catalytic cysteine displayed reduced motility and attenuated pathogenicity in a mouse model of infec-
tion. Future work will determine if other motile intracellular pathogens secrete proteins that fragment microtubules or
whether they recruit host factors to do it for them.
S. Yoshida et al. (2006). Science 314, 985–989.
An Expedited TRIP to the Bloodstream
The causative agent of typhoid, Salmonella typhi, and its mouse-adapted cousin,
Salmonella typhimurium, are engulfed by gut phagocytes and transported to the
bloodstream where they become efficiently disseminated, launching a systemic
infection. The rapidity with which these pathogens end up in the bloodstream can
be some sixty times greater than the normal migration time of phagocytes journeying
from the gut to the bloodstream. Now Worley et al. (2006) reveal that S. typhimurium
has a weapon among its arsenal of secreted virulence factors that enables it to sub-
vert the normal circuitous journey of the phagocyte, driving the host cell straight into
the bloodstream. This manipulated host cell motility is courtesy of SrfH, a bacterial
protein that is injected into the host cell cytoplasm via the Type III secretion system.
Apparently SrfH influences Rac signaling through its interactions with a protein,
thyroid receptor interacting protein 6 (TRIP6), that acts as a modulator or perhaps
as an adaptor protein for the Rac pathway. SrfH interacts with TRIP6 in a yeast
two-hybrid assay and colocalizes with TRIP6 in macrophage-like cells in culture.
Expression of SrfH in these cells triggers translocation of TRIP6 to the cytoskeleton
as well as membrane ruffling resembling the consequences of Rac pathway activa-
tion. Infection of macrophage-like and dendritic-like cells with wild-type bacteria,
but not bacteria with mutations in srfH, stimulated migration of the host cells. Finally,
in amousemodel of infection, a greater number of wild-typeSalmonellawere detected in the bloodstream compared
with the srfHmutantSalmonella shortly after ingestion of the bacteria. The next stepwill be to elucidate howSrfH and
potentially other virulence factors suppress the ability of the host cell to divert or stall the pathogen’s route to its
target destination.
M. Worley et al. (2006). PNAS 103, 17915–17920.
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Legionella Targets Host Elongation Factor
One way in which intracellular pathogens seize control of a eukaryotic host cell is by inhibiting eukaryotic pro-
tein synthesis. Protein synthesis can be blocked by de-purinating ribosomal RNA (e.g., by Shiga toxin) or by
ADP-ribosylating the elongation factor eEF2 (e.g., by diphtheria toxin). Recently Belyi et al. (2006) discovered
a new mechanism of translation inhibition in host cells by bacteria. Legionella pneumophila produces a glucosyl-
transferase, Lgt1, that adds a glucosemolecule to, or glucosylates, a serine in theGTPase domain of a different elon-
gation factor called eEF1A. Lgt1—but not Lgt1 carrying a mutation in the glucosyltransferase DXD motif—inhibits
eukaryotic protein synthesis both in vitro and in embryonic bovine lung cells. Cells into which Lgt1 was introduced
also displayed gross morphological changes correlated with eEF1A glucosylation, although it is uncertain whether
this effect is direct or indirect. Other pathogens also use glucosylation of various host cell macromolecules (e.g.,
Clostridium toxins glucosylate Rho proteins) as a virulence strategy. However, it is still not clear how glucosylation
of eEF1A impairs its function, nor how its inhibition promotes L. pneumophila infection.
Y. Belyi et al. (2006). PNAS 103, 16953–16958.
RIGging Viral Recognition
Host cells can combat viral infection by producing interferons that limit virus replication. The
host RNA helicase, RIG-I, is known to be important for launching an antiviral immune response
upon recognition of viral RNA in the host cell cytoplasm. The basis for RIG-I’s ability to discrim-
inate viral RNA from host RNA has been unclear. Now reports from Hornung et al. (2006) and
Pichlmair et al. (2006) indicate that a 50 triphosphate group is a critical distinguishing feature of
viral RNA. Hornung et al. determined that engineered RNA molecules could only elicit an inter-
feron response from monocytes if they harbored a 50 triphosphate group but not if the triphos-
phate group had been removed enzymatically, had been masked by a synthetic 7-methyl
guanosine cap, or if the RNA contained certain nucleoside modifications known to be present
in ribosomal RNA. They then showed that rabies virus RNA elicted an immune response from
host cells unless the RNA had been treatedwith a phosphatase enzyme, providing evidence for
a critical role of 50 triphosphate recognition in viral infection. Similarly, Pichlmair et al. demon-
strated that influenza A viral RNA that normally contains a 50 triphosphate group fails to elicit an
immune response if it has been dephosphorylated. The immune response to viral RNA was dependent on the pres-
ence of the RIG-I protein. An important aspect of these experiments is the demonstration that if a 50 triphosphate is
present, both single-stranded and double-stranded RNA are capable of activating RIG-I. These data challenge the
notion that a critical immunogenic feature of viral RNA is long stretches of double-stranded RNA. Instead, it seems,
the host cell takes advantage of a chemical difference between host RNA and viral RNA: most eukaryotic RNAs have
their 50 triphosphate groups removed or capped in RNA-processing steps or contain nucleoside modifications. Both
studies show that RIG-I forms a stable complex with RNA molecules harboring a 50 triphosphate group but not with
those that lack this chemical tag.
The Pichlmair et al. study offers insights into how the influenza A virus counteracts the RIG-I-mediated immune
response. The influenza A protein NS1 can suppress the host cell response to viral RNA. NS1 appears to bind to
RIG-I—it colocalizes with RIG-I in virus-infected cells and can be coprecipitated with RIG-I from infected cell lysates.
Additionally, NS1 can be recruited into a complex with RIG-I and viral RNA. Mutations that weaken the anti-immune
activity of NS1 also weaken the stability of its binding to the RIG-I-viral RNA complex. Thus NS1 most likely sup-
presses the RIG-I-mediated immune response to viral RNA through interaction with RIG-I. It will be interesting to
learn if other viruses have evolved mechanisms to evade RIG-I recognition, and if features beyond the presence
of the 50 triphosphate group, such as additional nucleoside modifications described by Hornung et al., are sufficient
to distinguish viral RNA from host RNA. Intriguingly, a few eukaryotic RNAs, such as 7SL RNAs in the cytoplasm, do
have the 50 triphosphate group, yet they do not elicit an immune response.
V. Hornung et al. (2006). Science 314, 994–997.
A. Pichlmair et al. (2006). Science 314, 997–1001.
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